Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings

Krista Barclay , Robert Carruthers , Anthony Traboulsee , Ann D. Bass , Christopher Laganke , Antonio Bertolotto , Aaron Boster , Elisabeth G. Celius , Jerome de Seze (1) , Dionisio Dela Cruz , Mario Habek , Jong-Mi Lee , Volker Limmroth , Sven G. Meuth , Celia Oreja-Guevara , Patricia Pagnotta , Cindy Vos , Tjalf Ziemssen , Darren P. Baker , Bart Van Wijmeersch

1 BMNST - Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques

Domaines: Neurosciences [q-bio.NC]

Krista Barclay, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher Laganke, et al.. Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. Frontiers in Neurology, 2019, 10, ⟨10.3389/fneur.2019.00253⟩. ⟨hal-02554077⟩